Vivoryon Therapeutics to Attend Upcoming Investor Conferences

On March 3, 2020 Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), reported that its management will be presenting at and attending the following upcoming conferences in March 2020 (Press release, Vivoryon Therapeutics, MAR 3, 2020, View Source [SID1234555091]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BioCapital Europe

Date: Thursday, March 12, 2020

Presentation: March 12, 2020, at 2:30 pm CET

Location: Amsterdam, The Netherlands

Attendee: Dr. Ulrich Dauer, Chief Executive Officer

BIO Europe Spring

Date: Thursday, March 23-25, 2020

Presentation: March 23, 2020, at 10:15 am CET

Location: Paris, France

Attendee: Dr. Ulrich Dauer, Chief Executive Officer